meclofenamic acid and tetraethylammonium

meclofenamic acid has been researched along with tetraethylammonium in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adnot, S; Carville, C; Chabrier, PE; Eddahibi, S; Levame, M; Mannan, M; Polak, J; Raffestin, B; Springall, D1
Diéguez, G; Fernández, N; García-Villalón, AL; Martínez, MA; Martínez-León, JB; Monge, L; Sanz, E1
Bohlen, HG; Nase, GP; Tuttle, J1
Amezquita, YM; Climent, B; Diéguez, G; Fernández, N; García-Villalón, AL; Monge, L; Sánchez, A1

Other Studies

4 other study(ies) available for meclofenamic acid and tetraethylammonium

ArticleYear
Dilator effect of endothelins in pulmonary circulation: changes associated with chronic hypoxia.
    The American journal of physiology, 1993, Volume: 265, Issue:6 Pt 1

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arginine; Autoradiography; Dose-Response Relationship, Drug; Endothelins; Glyburide; Guanidines; Hypoxia; In Vitro Techniques; Iodine Radioisotopes; Lung; Male; Meclofenamic Acid; Nitroarginine; Pentanoic Acids; Pinacidil; Potassium Channel Blockers; Prostaglandin Endoperoxides, Synthetic; Pulmonary Circulation; Pyridines; Rats; Rats, Wistar; Receptors, Endothelin; Tetraethylammonium; Tetraethylammonium Compounds; Thromboxane A2; Thromboxane-A Synthase; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents

1993
Relaxation by urocortin of human saphenous veins.
    British journal of pharmacology, 2002, Volume: 136, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Charybdotoxin; Corticotropin-Releasing Hormone; Cyclooxygenase Inhibitors; Endothelin-1; Female; Humans; In Vitro Techniques; Male; Meclofenamic Acid; Middle Aged; Muscle Relaxation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Potassium Channel Blockers; Potassium Channels; Prostaglandins; Saphenous Vein; Tetraethylammonium; Urocortins

2002
Reduced perivascular PO2 increases nitric oxide release from endothelial cells.
    American journal of physiology. Heart and circulatory physiology, 2003, Volume: 285, Issue:2

    Topics: Adenosine; Animals; Carbon Dioxide; Cyclooxygenase Inhibitors; Embolism, Air; Endothelium, Vascular; Enzyme Inhibitors; Male; Meclofenamic Acid; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxygen; Partial Pressure; Potassium Channel Blockers; Potassium Channels; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Tetraethylammonium; Vasodilation

2003
Mechanisms of the protective effects of urocortin on coronary endothelial function during ischemia-reperfusion in rat isolated hearts.
    British journal of pharmacology, 2005, Volume: 145, Issue:4

    Topics: Acetylcholine; Alkaloids; Animals; Benzophenanthridines; Cardiovascular Agents; Corticotropin-Releasing Hormone; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Glyburide; Heart; In Vitro Techniques; Male; Meclofenamic Acid; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Perfusion; Phenanthridines; Protein Kinase C; Rats; Rats, Sprague-Dawley; Tetraethylammonium; Urocortins; Vasodilator Agents

2005